BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35438562)

  • 1. MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.
    Zhang M; Wong SW; Wright JN; Wagner MW; Toescu S; Han M; Tam LT; Zhou Q; Ahmadian SS; Shpanskaya K; Lummus S; Lai H; Eghbal A; Radmanesh A; Nemelka J; Harward S; Malinzak M; Laughlin S; Perreault S; Braun KRM; Lober RM; Cho YJ; Ertl-Wagner B; Ho CY; Mankad K; Vogel H; Cheshier SH; Jacques TS; Aquilina K; Fisher PG; Taylor M; Poussaint T; Vitanza NA; Grant GA; Pfister S; Thompson E; Jaju A; Ramaswamy V; Yeom KW
    Radiology; 2022 Aug; 304(2):406-416. PubMed ID: 35438562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Assist for Pediatric Posterior Fossa Tumor Diagnosis: A Multinational Study.
    Zhang M; Wong SW; Wright JN; Toescu S; Mohammadzadeh M; Han M; Lummus S; Wagner MW; Yecies D; Lai H; Eghbal A; Radmanesh A; Nemelka J; Harward S; Malinzak M; Laughlin S; Perreault S; Braun KRM; Vossough A; Poussaint T; Goetti R; Ertl-Wagner B; Ho CY; Oztekin O; Ramaswamy V; Mankad K; Vitanza NA; Cheshier SH; Said M; Aquilina K; Thompson E; Jaju A; Grant GA; Lober RM; Yeom KW
    Neurosurgery; 2021 Oct; 89(5):892-900. PubMed ID: 34392363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients.
    Dasgupta A; Gupta T; Pungavkar S; Shirsat N; Epari S; Chinnaswamy G; Mahajan A; Janu A; Moiyadi A; Kannan S; Krishnatry R; Sastri GJ; Jalali R
    Neuro Oncol; 2019 Jan; 21(1):115-124. PubMed ID: 29846693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Texture Analysis of T1-Weighted Contrast-Enhanced Magnetic Resonance Imaging Potentially Predicts Outcomes of Patients with Non-Wingless-Type/Non-Sonic Hedgehog Medulloblastoma.
    Li J; Chen C; Fu R; Zhang Y; Fan Y; Xu J; Cen Y
    World Neurosurg; 2020 May; 137():e27-e33. PubMed ID: 31589984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.
    Iv M; Zhou M; Shpanskaya K; Perreault S; Wang Z; Tranvinh E; Lanzman B; Vajapeyam S; Vitanza NA; Fisher PG; Cho YJ; Laughlin S; Ramaswamy V; Taylor MD; Cheshier SH; Grant GA; Young Poussaint T; Gevaert O; Yeom KW
    AJNR Am J Neuroradiol; 2019 Jan; 40(1):154-161. PubMed ID: 30523141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine-learning approach to predict molecular subgroups of medulloblastoma using multiparametric MRI-based tumor radiomics.
    Saju AC; Chatterjee A; Sahu A; Gupta T; Krishnatry R; Mokal S; Sahay A; Epari S; Prasad M; Chinnaswamy G; Agarwal JP; Goda JS
    Br J Radiol; 2022 Jun; 95(1134):20211359. PubMed ID: 35262407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance radiomics features and prognosticators in different molecular subtypes of pediatric Medulloblastoma.
    Chang FC; Wong TT; Wu KS; Lu CF; Weng TW; Liang ML; Wu CC; Guo WY; Chen CY; Hsieh KL
    PLoS One; 2021; 16(7):e0255500. PubMed ID: 34324588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry.
    Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R
    J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of tumor location on subtypes of medulloblastoma.
    Teo WY; Shen J; Su JM; Yu A; Wang J; Chow WY; Li X; Jones J; Dauser R; Whitehead W; Adesina AM; Chintagumpala M; Man TK; Lau CC
    Pediatr Blood Cancer; 2013 Sep; 60(9):1408-10. PubMed ID: 23512859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic Resonance Imaging in the Contemporary Management of Medulloblastoma: Current and Emerging Applications.
    Dasgupta A; Maitre M; Pungavkar S; Gupta T
    Methods Mol Biol; 2022; 2423():187-214. PubMed ID: 34978700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI Radiomics Signature of Pediatric Medulloblastoma Improves Risk Stratification Beyond Clinical and Conventional MR Imaging Features.
    Zheng H; Li J; Liu H; Ting G; Yin Q; Li R; Liu M; Zhang Y; Duan S; Li Y; Wang D
    J Magn Reson Imaging; 2023 Jul; 58(1):236-246. PubMed ID: 36412264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of apparent diffusion coefficient histogram metrics for differentiating pediatric medulloblastoma histological variants and molecular groups.
    Gonçalves FG; Tierradentro-Garcia LO; Kim JDU; Zandifar A; Ghosh A; Viaene AN; Khrichenko D; Andronikou S; Vossough A
    Pediatr Radiol; 2022 Dec; 52(13):2595-2609. PubMed ID: 35798974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical Surrogates for Molecular Stratification in Medulloblastoma.
    Chinnam D; Saraswati A; Jogunoori S; Verma A; Kiran T; Salunke P; Gupta N; Kumar N; Madan R; Radotra BD; Gupta K
    Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):561-568. PubMed ID: 37471625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblastoma: Distinctive Histo-Molecular Correlation with Clinical Profile, Radiologic Characteristics, and Surgical Outcome.
    Narayan V; Sugur H; Jaiswal J; Arvinda HR; Arivazhagan A; Somanna S; Santosh V
    Pediatr Neurosurg; 2019; 54(5):329-340. PubMed ID: 31480064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.
    Mynarek M; Obrecht D; Sill M; Sturm D; Kloth-Stachnau K; Selt F; Ecker J; von Hoff K; Juhnke BO; Goschzik T; Pietsch T; Bockmayr M; Kool M; von Deimling A; Witt O; Schüller U; Benesch M; Gerber NU; Sahm F; Jones DTW; Korshunov A; Pfister SM; Rutkowski S; Milde T
    Acta Neuropathol; 2023 Jan; 145(1):97-112. PubMed ID: 36459208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI Characteristics of Primary Tumors and Metastatic Lesions in Molecular Subgroups of Pediatric Medulloblastoma: A Single-Center Study.
    Mata-Mbemba D; Zapotocky M; Laughlin S; Taylor MD; Ramaswamy V; Raybaud C
    AJNR Am J Neuroradiol; 2018 May; 39(5):949-955. PubMed ID: 29545246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-MRI radiomics enables the prediction of preoperative cerebral spinal fluid dissemination in children with medulloblastoma.
    Zheng H; Li J; Liu H; Wu C; Gui T; Liu M; Zhang Y; Duan S; Li Y; Wang D
    World J Surg Oncol; 2021 Apr; 19(1):134. PubMed ID: 33888125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation Between Ependymoma and Medulloblastoma in Children with Radiomics Approach.
    Dong J; Li L; Liang S; Zhao S; Zhang B; Meng Y; Zhang Y; Li S
    Acad Radiol; 2021 Mar; 28(3):318-327. PubMed ID: 32222329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.